Mackenzie Financial’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
659,120
+322,128
+96% +$1.02M ﹤0.01% 947
2025
Q4
$1.24M Buy
336,992
+64,034
+23% +$207K ﹤0.01% 999
2025
Q3
$723K Buy
272,958
+261,258
+2,233% +$505K ﹤0.01% 1156
2025
Q2
$11.5K Sell
11,700
-111,415
-90% -$112K ﹤0.01% 1687
2025
Q1
$177K Sell
123,115
-20,137
-14% -$37.1K ﹤0.01% 1537
2024
Q4
$315K Buy
143,252
+76,965
+116% +$180K ﹤0.01% 1362
2024
Q3
$109K Buy
66,287
+31,033
+88% +$62.7K ﹤0.01% 1472
2024
Q2
$78.3K Buy
35,254
+18,036
+105% +$42.4K ﹤0.01% 1456
2024
Q1
$46.1K Buy
17,218
+3,827
+29% +$9.3K ﹤0.01% 1490
2023
Q4
$40K Sell
13,391
-19,227
-59% -$24.9K ﹤0.01% 1458
2023
Q3
$31.5K Buy
32,618
+5,341
+20% +$7.73K ﹤0.01% 1438
2023
Q2
$38.7K Sell
27,277
-60,060
-69% -$83.9K ﹤0.01% 1475
2023
Q1
$139K Buy
87,337
+19,494
+29% +$101K ﹤0.01% 1380
2022
Q4
$423K Buy
+67,843
New +$485K ﹤0.01% 984

Other funds holding ESPR